Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/21/2005 | CN1232280C Medicine composition for anti-virus treating SARS |
12/21/2005 | CN1232259C Medicine composition with two-way immune regulation function by oral cavity local administration |
12/21/2005 | CN1232250C Andrographolide lactone microcapsule and its preparation method |
12/20/2005 | US6977300 A2B adenosine receptor antagonists |
12/20/2005 | US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents |
12/20/2005 | US6977265 Piperidine CCR-3 receptor antagonists |
12/20/2005 | US6977264 For therapy and prophylaxis of obesity, diabetes |
12/20/2005 | US6977263 Chemical compounds |
12/20/2005 | US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent) |
12/20/2005 | US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
12/20/2005 | CA2338206C High affinity ligands for nociceptin receptor orl-1 |
12/20/2005 | CA2324324C Treatment of pulmonary hypertension |
12/20/2005 | CA2092896C Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
12/15/2005 | WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer |
12/15/2005 | WO2005118579A2 Thiazole derivatives as chemokine receptor antagonists |
12/15/2005 | WO2005118576A1 Constrained himbacine analogs as thrombin receptor antagonists |
12/15/2005 | WO2005118543A1 Kinase inhibitor and use thereof |
12/15/2005 | WO2005117961A1 Sars virus vaccine with adenovirus carrier and preparation method thereof , and use of sars virus s gene for preparation of vaccine |
12/15/2005 | WO2005117890A2 Thienopyrimidines and thiazolopyrimidines for use in medicine |
12/15/2005 | WO2003062370A3 Multimeric proteins and methods of making and using same |
12/15/2005 | US20050277688 Napadisylate salt formation of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide in an aqueous isopropanol or ethanol solution; combined with a beta 2 adrenergic receptor agonist or a steroidal anti-inflammatory agent; COPD, asthma; muscarinic receptor antagonists, bronchodilators |
12/15/2005 | US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
12/15/2005 | US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide |
12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
12/15/2005 | US20050277609 Immunostimulatory nucleic acid molecules |
12/15/2005 | US20050277604 Immunostimulatory nucleic acid molecules |
12/15/2005 | US20050276853 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
12/15/2005 | US20050276852 Sustained release formulations of guaifenesin and additional drug ingredients |
12/15/2005 | US20050276789 Immunostimulatory oligonucleotides and uses thereof |
12/15/2005 | CA2568524A1 Modulators of muscarinic receptors |
12/14/2005 | EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity |
12/14/2005 | EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
12/14/2005 | EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses |
12/14/2005 | EP1604665A1 C-kit kinase inhibitor |
12/14/2005 | EP1603565A1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
12/14/2005 | EP1603547A1 Trospium containing compositions |
12/14/2005 | EP1496902B1 Medicament containing steroids and a novel anticholinergic drug |
12/14/2005 | EP1440052B1 Benzamide derivatives as antagonists of orexin receptors |
12/14/2005 | EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors |
12/14/2005 | EP1326858B1 Piperidine compounds as anti-allergic |
12/14/2005 | EP1284771B1 Aerosol container for formulations of salmeterol xinafoate |
12/14/2005 | EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
12/14/2005 | EP1261309B1 Device for calculating elixir doses appropriate for a patient's weight |
12/14/2005 | EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
12/14/2005 | EP1223931B1 Use of a imidazole derivative for the treatment or prevention of hypotension and shock |
12/14/2005 | EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release |
12/14/2005 | EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
12/14/2005 | EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity |
12/14/2005 | EP1082103B1 Spill resistant pharmaceutical compositions |
12/14/2005 | EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation |
12/14/2005 | CN1708302A Pharmacological treatment for sleep apnea |
12/14/2005 | CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
12/14/2005 | CN1231479C Naphthostyrils compounds |
12/14/2005 | CN1231467C High affinity ligands for nociceptin receptor ORL-1 |
12/14/2005 | CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof |
12/14/2005 | CN1231459C Novel aminobenzophenones |
12/14/2005 | CN1231258C Interferon lozenge ice block and making method and use thereof |
12/14/2005 | CN1231250C Chinese medicine preparation for treating acute and chronic pharyngitis, preparing method thereof |
12/14/2005 | CN1231238C Chinese medicine for inflammation and swelling |
12/14/2005 | CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
12/13/2005 | US6974836 Diamines as modulators of chemokine receptor activity |
12/13/2005 | US6974831 sPLA2 inhibitors |
12/13/2005 | US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
12/13/2005 | US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
12/13/2005 | US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
12/13/2005 | US6974792 Alpha 1-antitrypsin preparation as well as a method for producing the same |
12/13/2005 | US6974594 Method of preparing biological materials and preparations produced using same |
12/13/2005 | US6974568 Treatment for cough |
12/13/2005 | CA2271054C Substituted phenols and thiophenols useful as antioxidant agents |
12/13/2005 | CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
12/13/2005 | CA2090634C Novel cyclosporins |
12/11/2005 | CA2566213A1 Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor |
12/10/2005 | CA2507847A1 Prostaglandin reductase |
12/10/2005 | CA2507738A1 Modulation of peroxisome proliferator-activated receptors |
12/08/2005 | WO2005115430A1 Treatment of inflammatory airway disease |
12/08/2005 | WO2005115405A1 Methods for treating or preventing restenosis and other vascular proliferative disorders |
12/08/2005 | WO2005054432A3 Gene transfer for regulating smooth muscle tone |
12/08/2005 | WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
12/08/2005 | US20050272936 Imidazolium cxcr3 inhibitors |
12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
12/08/2005 | US20050272821 Levalbuterol hydrochloride Polymorph A |
12/08/2005 | US20050272789 Triazole-derived kinase inhibitors and uses thereof |
12/08/2005 | US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
12/08/2005 | US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
12/08/2005 | US20050272756 Pyridopyrrolizine and pyridoindolizine derivatives |
12/08/2005 | US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide |
12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
12/08/2005 | US20050272732 5-ethyl-imidazo (5,1-F) (1,2,4,) triazin-4 (3h)-ones as phosphodiesterase inhibitors |
12/08/2005 | US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
12/08/2005 | US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death |
12/08/2005 | US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
12/08/2005 | US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
12/08/2005 | US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
12/08/2005 | US20050272036 Ketones |
12/08/2005 | US20050271743 Treatment of inflammatory skin conditions |
12/08/2005 | US20050271674 Methods and compositions for modulating the immune system of animals |
12/08/2005 | US20050271673 Trifunctional reagent for conjugation to a biomolecule |
12/08/2005 | US20050269722 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
12/08/2005 | US20050269546 Valve with a two-component seal |
12/08/2005 | US20050268908 Medicament dispenser |